{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T06:31:40Z","timestamp":1782973900520,"version":"3.54.5"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"DOI":"10.7759\/cureus.111928","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:07:26Z","timestamp":1782968846000},"source":"Crossref","is-referenced-by-count":0,"title":["Improvement of Refractory Cutaneous Ulcers and Pulmonary Arterial Hypertension Following Rituximab and Mycophenolate Mofetil Therapy in Anti-melanoma Differentiation-Associated Gene 5 (Anti-MDA5) Antibody-Positive Dermatomyositis"],"prefix":"10.7759","author":[{"given":"Takuya","family":"Yasuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuyoshi","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"Hagino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21023","article-title":"Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis","volume":"52","author":"Sato S","year":"2005","unstructured":"Sato S, Hirakata M, Kuwana M, et al.. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 2005, 52:1571-6. 10.1002\/art.21023","journal-title":"Arthritis Rheum"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/art.24621","article-title":"RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease","volume":"60","author":"Sato S","year":"2009","unstructured":"Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, Fujita T, Kuwana M. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease. Arthritis Rheum. 2009, 60:2193-200. 10.1002\/art.24621","journal-title":"Arthritis Rheum"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-023-00486-7","article-title":"Pulmonary hypertension","volume":"10","author":"Mocumbi A","year":"2024","unstructured":"Mocumbi A, Humbert M, Saxena A, et al.. Pulmonary hypertension. Nat Rev Dis Primers. 2024, 10:1. 10.1038\/s41572-023-00486-7","journal-title":"Nat Rev Dis Primers"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.4402","article-title":"Diagnosis and treatment of pulmonary arterial hypertension: a review","volume":"327","author":"Ruopp NF","year":"2022","unstructured":"Ruopp NF, Cockrill BA. Diagnosis and treatment of pulmonary arterial hypertension: a review. JAMA. 2022, 327:1379-91. 10.1001\/jama.2022.4402","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009727","article-title":"Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: study of 121 cases","volume":"95","author":"Allenbach Y","year":"2020","unstructured":"Allenbach Y, Uzunhan Y, Toquet S, et al.. Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: study of 121 cases. Neurology. 2020, 95:e70-8. 10.1212\/WNL.0000000000009727","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert M","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM, et al.. 2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022, 43:3618-731. 10.1093\/eurheartj\/ehac237","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00090814","article-title":"Connective tissue disease-associated pulmonary arterial hypertension: \"Beijing style\"","volume":"44","author":"Chung L","year":"2014","unstructured":"Chung L, Kawut SM. Connective tissue disease-associated pulmonary arterial hypertension: \"Beijing style\". Eur Respir J. 2014, 44:839-41. 10.1183\/09031936.00090814","journal-title":"Eur Respir J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004911","article-title":"Pulmonary arterial hypertension in idiopathic inflammatory myopathies: data from the French pulmonary hypertension registry and review of the literature","volume":"95","author":"Sanges S","year":"2016","unstructured":"Sanges S, Yelnik CM, Sitbon O, et al.. Pulmonary arterial hypertension in idiopathic inflammatory myopathies: data from the French pulmonary hypertension registry and review of the literature. Medicine (Baltimore). 2016, 95:e4911. 10.1097\/MD.0000000000004911","journal-title":"Medicine (Baltimore)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202844","article-title":"Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids","volume":"72","author":"Condon MB","year":"2013","unstructured":"Condon MB, Ashby D, Pepper RJ, et al.. Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids. Ann Rheum Dis. 2013, 72:1280-6. 10.1136\/annrheumdis-2012-202844","journal-title":"Ann Rheum Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/art.41105","article-title":"Multicenter prospective study of the efficacy and safety of combined immunosuppressive therapy with high-dose glucocorticoid, tacrolimus, and cyclophosphamide in interstitial lung diseases accompanied by anti-melanoma differentiation-associated gene 5-positive dermatomyositis","volume":"72","author":"Tsuji H","year":"2020","unstructured":"Tsuji H, Nakashima R, Hosono Y, et al.. Multicenter prospective study of the efficacy and safety of combined immunosuppressive therapy with high-dose glucocorticoid, tacrolimus, and cyclophosphamide in interstitial lung diseases accompanied by anti-melanoma differentiation-associated gene 5-positive dermatomyositis. Arthritis Rheumatol. 2020, 72:488-98. 10.1002\/art.41105","journal-title":"Arthritis Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/art.20676","article-title":"Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist","volume":"50","author":"Korn JH","year":"2004","unstructured":"Korn JH, Mayes M, Matucci Cerinic M, et al.. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum. 2004, 50:3985-93. 10.1002\/art.20676","journal-title":"Arthritis Rheum"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199312303292704","article-title":"A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas MC","year":"1993","unstructured":"Dalakas MC, Illa I, Dambrosia JM, et al.. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med. 1993, 329:1993-2000. 10.1056\/NEJM199312303292704","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-236431","article-title":"MDA-5 dermatomyositis complicated by interstitial lung disease and cutaneous ulcers: successful treatment with corticosteroids, mycophenolate mofetil and intravenous immunoglobulin","volume":"13","author":"Stager K","year":"2020","unstructured":"Stager K, Wise L. MDA-5 dermatomyositis complicated by interstitial lung disease and cutaneous ulcers: successful treatment with corticosteroids, mycophenolate mofetil and intravenous immunoglobulin. BMJ Case Rep. 2020, 13:e236431. 10.1136\/bcr-2020-236431","journal-title":"BMJ Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1159\/000346573","article-title":"Response of mucocutaneous lesions to rituximab in a case of melanoma differentiation antigen 5-related dermatomyositis","volume":"225","author":"Clottu A","year":"2012","unstructured":"Clottu A, Laffitte E, Prins C, Chizzolini C. Response of mucocutaneous lesions to rituximab in a case of melanoma differentiation antigen 5-related dermatomyositis. Dermatology. 2012, 225:376-80. 10.1159\/000346573","journal-title":"Dermatology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.1.182","article-title":"Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension","volume":"130","author":"Sanchez O","year":"2006","unstructured":"Sanchez O, Sitbon O, Ja\u00efs X, Simonneau G, Humbert M. Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension. Chest. 2006, 130:182-9. 10.1378\/chest.130.1.182","journal-title":"Chest"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/apha.14084","article-title":"Calcineurin inhibition, cardiovascular consequences, vascular resistance, and potential responses","volume":"240","author":"Luft FC","year":"2024","unstructured":"Luft FC. Calcineurin inhibition, cardiovascular consequences, vascular resistance, and potential responses. Acta Physiol (Oxf). 2024, 240:e14084. 10.1111\/apha.14084","journal-title":"Acta Physiol (Oxf)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/art.21263","article-title":"Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus","volume":"52","author":"Somers EC","year":"2005","unstructured":"Somers EC, Marder W, Christman GM, Ognenovski V, McCune WJ. Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus. Arthritis Rheum. 2005, 52:2761-7. 10.1002\/art.21263","journal-title":"Arthritis Rheum"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1413204","article-title":"Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy","volume":"372","author":"Moore HC","year":"2015","unstructured":"Moore HC, Unger JM, Phillips KA, et al.. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med. 2015, 372:923-32. 10.1056\/NEJMoa1413204","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/506721-improvement-of-refractory-cutaneous-ulcers-and-pulmonary-arterial-hypertension-following-rituximab-and-mycophenolate-mofetil-therapy-in-anti-melanoma-differentiation-associated-gene-5-anti-mda5-antibody-positive-dermatomyositis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:07:28Z","timestamp":1782968848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/506721-improvement-of-refractory-cutaneous-ulcers-and-pulmonary-arterial-hypertension-following-rituximab-and-mycophenolate-mofetil-therapy-in-anti-melanoma-differentiation-associated-gene-5-anti-mda5-antibody-positive-dermatomyositis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.111928","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,1]]}}}